$QNTA the Company submitted the final clinical trial data to the Dominican Republic (“DR”) Ministry of Health (“MoH”) for approval of the Company’s product, Escozine, as a COVID-19 treatment. https://finance.yahoo.com/news/medolife-rx-submits-final-clinical-130000052.html